Nicaragua Pharmaceuticals & Healthcare Q2 2018
Nicaragua’s pharmaceutical market growth will be supported by government efforts to expand universal healthcare in anattempt to make it a higher priority market within Latin and Central America. However, the country will remain a relativelyunattractive market for pharmaceutical companies, deterred by downside risks such as the small absolute market size, low percapita pharmaceutical expenditure and the persistently challenging business environment. We maintain our view that whenmultinational drugmakers consider investment or expansion into Central America, Costa Rica remains the more attractive choice.
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.Download eBook